Appili Therapeutics Inc. Forecasted to Post Q1 2023 Earnings of ($0.03) Per Share (TSE:APL)
Appili Therapeutics Inc. Forecasted to Post Q1 2023 Earnings of ($0.03) Per Share (TSE:APL)
Appili Therapeutics Inc. (TSE:APL – Get Rating) – Equities researchers at Zacks Small Cap issued their Q1 2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a research note issued on Thursday, July 14th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings per share of ($0.03) for the quarter. Zacks Small Cap also issued estimates for Appili Therapeutics' Q2 2023 earnings at ($0.02) EPS, Q3 2023 earnings at ($0.02) EPS and Q4 2023 earnings at ($0.02) EPS.
Appili治疗公司(多伦多证券交易所股票代码：APL-GET评级)--Zack Small Cap的股票研究人员在7月14日星期四发布的一份研究报告中发布了他们对Appili治疗公司股票2023年第一季度每股收益(EPS)的估计。Zack Small Cap分析师D·鲍茨预计，该公司本季度每股收益将达到0.03美元。Zack Small Cap还发布了对Appili Treeutics 2023年第二季度每股收益(0.02美元)、2023年第三季度每股收益(0.02美元)和2023年第四季度每股收益(0.02美元)的估计。
Appili Therapeutics Price Performance
阿普利治疗公司性价比
See Also
另请参阅
- MarketBeat: Week in Review 7/11 – 7/15
- Is Coupang's Stock On The Verge Of A Turnaround?
- Should You Have These Two Banks In Your Portfolio?
- Verint Systems Stock is a Customer Engagement Play
- Why Shopify Stock Split...And is as Shoppable as Ever
- MarketBeat：回顾一周7/11-7/15
- Coupang的股票即将翻身吗？
- 你的投资组合中应该有这两家银行吗？
- Verint Systems Stock是一场客户互动活动
- 为什么Shopify股票拆分...并一如既往地适合购物
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
获得《阿普利治疗日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Appili Treateutics和相关公司的最新新闻和分析师评级的每日简要摘要。
